Horizon Kinetics Asset Management LLC Organon & Co. Transaction History

Horizon Kinetics Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $265 - $380	16 Added 0.07%	22,342 $387,000
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $87,158 - $111,401	4,523 Added 25.41%	22,326 $464,000
Q1 2023 May 12, 2023	SELL	$21.42 - $32.08 $95,104 - $142,435	-4,440 Reduced 19.96%	17,803 $418,000
Q4 2022 Feb 07, 2023	BUY	$23.31 - $28.61 $71,771 - $88,090	3,079 Added 16.07%	22,243 $621,000
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $129,752 - $189,916	5,545 Added 40.72%	19,164 $448,000
Q2 2022 Aug 05, 2022	BUY	$31.66 - $38.9 $126,101 - $154,938	3,983 Added 41.33%	13,619 $460,000
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $87,026 - $112,490	2,858 Added 42.17%	9,636 $337,000
Q4 2021 Feb 15, 2022	BUY	$28.67 - $37.13 $194,325 - $251,667	6,778 New	6,778 $206,000

789

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.06B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.